Skip to main content

Lifevantage Corp

LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000849146

In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 2 sales; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 17, 2026
$60.6M
Insider buysLast 90 days, $6.07K in total
1
Insider sellsLast 90 days, $104.5K in total
2
13F holdersQ2 2026, −13 vs. previous quarter
88
13F valueReported value at the end of Q2 2026
$36.9M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2026
$182.6M
−20.1% year over year
Net income, FY2026
$5.07M
−48.3% year over year
Free cash flow, FY2026
$6.67M
−36.5% year over year
Revenue, Q1 FY2027
$37.1M
−22.0% year over year

Revenue flow, FY2026

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
906.6K
Shares sold short
Change
−69.4K
−7.1% vs. previous
Days to cover
42.11
At average daily volume

Superinvestors holding LFVN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding LFVN at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Lifevantage Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2026 (view filing)4:05 PM ETNov 124 daysBeindorff Michael ADirectorSSale−10.0K$4.89−$48.9K−24.0%31.6K after
Sep 17, 2026 (view filing)4:05 PM ETSep 152 daysLewis DarwinDirectorPPurchase+976$6.22+$6.07K+0.7%138.2K after10b5-1
Sep 14, 2026 (view filing)6:55 PM ETSep 11-143 daysCunningham KristenChief Sales OfficerSSale−9.00K$6.18−$55.6K−7.0%120.2K after2 lots
Jun 17, 2026 (view filing)Jun 152 daysLewis DarwinDirectorPPurchase+705$8.60+$6.06K+0.5%137.3K after10b5-1
Jun 5, 2026 (view filing)Jun 32 daysBeindorff Michael ADirectorSSale−10.0K$8.55−$85.5K−19.4%41.6K after
Mar 18, 2026 (view filing)Mar 162 daysLewis DarwinDirectorPPurchase+1.05K$5.23+$5.52K+0.8%136.6K after10b5-1
Mar 2, 2026 (view filing)Feb 26-Mar 24 daysDayton JuddDirectorPPurchase+33.2K$4.59+$152.4K+70.4%80.4K after3 lots
Feb 11, 2026 (view filing)Feb 92 daysLewis DarwinDirectorPPurchase+3.96K$5.22+$20.6K+3.0%135.5K after
Dec 17, 2025 (view filing)Dec 152 daysLewis DarwinDirectorPPurchase+805$6.54+$5.26K+0.6%131.6K after10b5-1
Nov 21, 2025 (view filing)Nov 192 daysBeindorff Michael ADirectorSSale−12.6K$6.42−$80.9K−22.3%43.8K after

Top 10 13F holders, Q2 2026

See all 88 holders

The largest institutional positions in Lifevantage Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding LFVN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Capital Management Corp1,878,411$11.7M1.76%−563,508−23.1%Reduced
Renaissance Technologies LLC669,418$4.18M0.01%−198,286−22.9%Reduced
Vanguard Capital Management LLC429,203$2.68M0.00%−219−0.1%Reduced
BlackRock, Inc.268,605$1.68M0.00%−501,093−65.1%Reduced
Dimensional Fund Advisors LP256,296$1.60M0.00%−19,900−7.2%Reduced
Envestnet Asset Management Inc229,907$1.43M0.00%+10,745+4.9%Added
Susquehanna International Group, LLP169,046$1.05M0.00%+169,046New
American Century Companies Inc144,386$901.0K0.00%+39,722+38.0%Added
Jane Street Group, LLC138,056$861.5K0.00%+138,056New
Geode Capital Management, LLC120,830$754.3K0.00%−140,362−53.7%Reduced

Holders of 5% or more of LFVN

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lifevantage Corp.

Largest holders of LFVN from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Capital Management Corp13G/A18.30%2.31M shares+3.40 ppfrom 14.90%Apr 23, 20257 filingsOct 22, 2026SEC
Renaissance Technologies LLC13G/A5.31%669.4K shares–Feb 11, 20215 filingsAug 13, 2026SEC